Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

154.52 +4.50 (+3.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,263,821
Open 150.01
Bid (Size) 153.99 (65)
Ask (Size) 154.52 (10)
Prev. Close 150.02
Today's Range 148.66 - 156.57
52wk Range 115.03 - 217.25
Shares Outstanding 385,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Credit Suisse's $17B Of AT1 Debt Written Down To Zero, Richard Branson's Virgin Orbit Plans Insolvency, Court Freezes Volkswagen's Russian Assets: Today's Top Stories
Reuters 
Via Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats 
Via News Direct
Topics Death Economy
Exposures COVID-19 Death Economy

Performance

YTD
-13.67%
-13.67%
1 Month
-3.48%
-3.48%
3 Month
-18.63%
-18.63%
6 Month
+20.81%
+20.81%
1 Year
-11.89%
-11.89%

More News

Read More
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via TheNewswire.com
Topics Death Economy
Exposures COVID-19 Death Economy
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
Via Benzinga
This Is What Whales Are Betting On Moderna
Via Benzinga
Looking At Moderna's Recent Unusual Options Activity
Via Benzinga
Why Moderna Stock Zoomed 7% Higher Today
Via The Motley Fool
2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market
Via The Motley Fool
Large Vaccine Players Including GSK, Moderna Prepare For Bird Flu Vaccine 'Just In Case'
Via Benzinga
12-Stock Portfolio -- 25 Growth Stocks to Buy Now
Via The Motley Fool
Better RSV Vaccine Stock: Pfizer, GSK, or Moderna?
Via The Motley Fool
What 13 Analyst Ratings Have To Say About Moderna
Via Benzinga
Is It Time to Buy the S&P 500's 2 Worst-Performing February Stocks?
Via The Motley Fool
This High-Growth Company Is Expanding. Time to Buy the Stock?
Via The Motley Fool
ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies
Via InvestorPlace
2 Top Biotech Stocks to Buy for the Long Haul
Via The Motley Fool
3 Vaccine Stocks to Watch for Their Post-Pandemic Moves
Via InvestorPlace
Moderna Announces Phase 2 Data on mRNA-4157/V940, an Investigational mRNA Personalized Cancer Vaccine, to be Presented at the 2023 AACR Annual Meeting
Via ACCESSWIRE
My Hedge Against The Silicon Valley Bank Crisis
Via Talk Markets
Is It Time to Buy the Nasdaq's 3 Worst-Performing February Stocks?
Via The Motley Fool
Did Elon Musk Just Put His Skepticism Behind And Warm Up To mRNA Tech That Powers Most COVID-19 Vaccines?
Via Benzinga
A Bull Market Is Coming: 5 Top Stocks to Buy Now
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
Via Benzinga
2 Top Biotech Stocks to Buy In March and Hold Forever
Via The Motley Fool
Moderna To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.